top of page

ANAVEX New Website - Untitled Page.png

Search

CTAD 2016 — Clinical Trials on Alzheimer's Disease

ANAVEX® Life Sciences Corp.
Nov 22, 2016
1 min read

Event: CTAD 2016 – Clinical Trials on Alzheimer’s Disease

Date/Time: Saturday, December 10, 2016 at 8.45 a.m. PT (Oral Communications Session)

Location: The Marriott Marquis San Diego Marina, San Diego

Recent Posts

Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East

Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East

Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease

Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease

Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference

Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference

bottom of page